ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO0124

Atypical Protein Kinase C Zeta Is Indispensable for Calcium Oxalate Crystal Clearance in a Dietary-Induced Mouse Model of Kidney Injury

Session Information

  • AKI: Mechanisms - 3
    November 08, 2025 | Location: Exhibit Hall, Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Acute Kidney Injury

  • 103 AKI: Mechanisms

Authors

  • Messing, Melina, University of California Santa Barbara, Santa Barbara, California, United States
  • Holznecht, Nickolas J., University of California Santa Barbara, Santa Barbara, California, United States
  • Strubl, Sebastian, University of California Santa Barbara, Santa Barbara, California, United States
  • Torres, Jacob A., University of California Santa Barbara, Santa Barbara, California, United States
  • Ngo, Emily Marie, University of California Santa Barbara, Santa Barbara, California, United States
  • Seligson, Anna Gabrielle, University of California Santa Barbara, Santa Barbara, California, United States
  • Krishnan, Shreya, University of California Santa Barbara, Santa Barbara, California, United States
  • Aceves, Brina A., University of California Santa Barbara, Santa Barbara, California, United States
  • Schimmel, Margaret, University of California Santa Barbara, Santa Barbara, California, United States
  • Weimbs, Thomas, University of California Santa Barbara, Santa Barbara, California, United States
Background

Previously, we showed that renal calcium oxalate (CaOx) crystal deposition triggers reversible tubular dilation to expel crystals from normal kidneys and accelerates disease progression in polycystic kidney disease (PKD) rodent models. Given that atypical protein kinase C zeta (PKCζ) expression is downregulated in patients with autosomal dominant polycystic kidney disease (ADPKD) and that restoration of PKCζ has been shown to improve the condition, we investigated the role of PKCζ in the kidneys during and after CaOx deposition.

Methods

To explore reversible tubular dilation and signaling activity in PKCζ-knockout (KO) kidneys following CaOx deposition, we administered a 0.67% sodium oxalate (NaOx) diet to P56 male wild-type and PKCζ-KO mice for up to 14 days, followed by a recovery period of up to 28 days after cessation of NaOx treatment.

Results

Both groups demonstrated substantial renal crystal deposition; however, wild-type mice remained healthy throughout the dietary intervention. In contrast, PKCζ-KO mice showed increased susceptibility to injury, leading to mortality around day 10. PKCζ-KO mice exhibited significantly higher crystal accumulation compared to wild-type and inability to excrete these crystals. The failure of PKCζ-KO mice to eliminate CaOx crystals appears to involve underlying mitochondrial dysfunction in PKCζ-deficient renal epithelial cells, with reduced TOMM20 expression. Additionally, while NFκB activation appeared reduced in epithelial cells, F4/80+ immune cells were elevated at baseline and post-injury, pointing to a possible dysregulation in epithelial-immune crosstalk.

Conclusion

These findings identify an unexpected critical role of PKCζ in the excretion of renal tubular CaOx crystals and suggest its potential as a therapeutic target for preventing chronic kidney disease progression following crystal-induced injury.

Funding

  • Private Foundation Support

Digital Object Identifier (DOI)